The effects of intradermal steroids on the pituitary-adrenal axis and the skin.
D000085:Acetates / Q000008:administration & dosage; D000328:Adult; D001284:Atrophy / Q000139:chemically induced; D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007271:Injections, Intradermal; D008297:Male; D010710:Phosphates / Q000008:administration & dosage; D010859:Pigmentation Disorders / Q000139:chemically induced; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D012867:Skin / Q000187:drug effects*; D013684:Telangiectasis / Q000139:chemically induced; D014221:Triamcinolone / Q000008:administration & dosage / Q000009:adverse effects*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects
D000085:Acetates; D010710:Phosphates; D014221:Triamcinolone; D001623:Betamethasone; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone